Therapeutic potential of phytoconstituents from Pilocarpus microphyllus Stapf ex Wardlew. and propolis in Alzheimer's disease: an Integrative Review
DOI:
https://doi.org/10.11606/issn.1679-9836.v103i2e-218782Keywords:
Alzheimer, Jaborandi, Neuroprotection, Propolis, PilocarpineAbstract
Introduction: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder characterized by the deterioration of cognitive functions, for which the available pharmacotherapy is not capable of effecting a cure. Objectives: To investigate the neuroprotective properties of phytoconstituents from Jaborandi (Pilocarpus microphyllus) and propolis as potential agents in the therapy of AD. Methodology: This is an integrative literature review study, in which the PICO strategy was followed in formulating the guiding question. Five databases were used: PubMed, Web of Science, Scopus, Embase, and Lilacs. The analysis was conducted with the descriptors "epiisopiloturine", "episopilosin", "pilocarpine", "macaubine", "propolis", "alzheimer" extracted from the DeCS (Health Sciences Descriptors) and Medical Subject Headings (MeSH). Keywords were isolated and combined using boolean operators AND and OR. Results: The search resulted in 602 studies identified in the databases, 337 were duplicates, leaving 265 for title and abstract reading, of which 250 were excluded. In the end, 10 studies were read in full and 08 studies were included in the scope of the review. The research evidenced neuroprotective activity for propolis, through antioxidative, anti-inflammatory, and anticholinesterase action, configuring it with therapeutic potential in AD. For pilocarpine, a substance with various clinical applications, few studies demonstrated a correlation with AD, in cognitive and behavioral improvement. Conclusion: Therefore, benefits for the use of propolis in cognitive dysfunctions are concluded, while for pilocarpine, this relationship was not established. It is necessary to develop research that elucidates the possible functional roles for these substances.
Downloads
References
Gulisano W, Maugeri D, Baltrons MA, Fà M, Amato A, Palmeri A, et al. Role of amyloid-β and tau proteins in Alzheimer's disease: confuting the amyloid cascade. J Alzheimer's Dis. 2018;64(s1):S611-S631. Doi: https://doi.org/10.3233/jad-189015
Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT. The epidemiology of Alzheimer’s disease modifiable risk factors and prevention. J Prev Alzheimers Dis. 2021;8:313-21. Doi: https://doi.org/10.14283/jpad.2021.15
Breijyeh Z, Karaman R. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules. 2020;25(24):5789. Doi: https://doi.org/10.3390/molecules25245789
Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease. Curr Neuropharmacol. 2020;18(11):1106-25. Doi: https://doi.org/10.2174/1570159X18666200528142429
Rostagno AA. Pathogenesis of Alzheimer’s Disease. Int J Mol Sci. 2022;24(1):107. Doi: https://doi.org/10.3390/ijms24010107
Habtemariam S. Natural products in Alzheimer’s disease therapy: would old therapeutic approaches fix the broken promise of modern medicines? Molecules. 2019;24(8):1519. Doi: https://doi.org/10.3390/molecules24081519
Singh AK, Rai SN, Maurya A, Mishra G, Awasthi R, Shakya A, et al. Therapeutic potential of phytoconstituents in management of Alzheimer's disease. Evid Based Complement Alternat Med. 2021;2021:1-19. Doi: https://doi.org/10.1155/2021/5578574
Sabá RT, Lameira OA, Luz JM, Gomes AP, Innecco R. Micropropagação do jaborandi. Hortic Bras. 2002;20(1). Doi: https://doi.org/10.1590/S0102-05362002000100021
Rocha JA, Andrade IM, Véras LM, Quelemes PV, Lima DF, Soares MJ, et al. Anthelmintic, antibacterial and cytotoxicity activity of imidazole alkaloids from Pilocarpus microphyllus leaves. Phytother Res. 2017;31(4):624-30. Doi: https://doi.org/10.1002/ptr.5771
Prediger RD, De-Mello N, Takahashi RN. Pilocarpine improves olfactory discrimination and social recognition memory deficits in 24-month-old rats. Eur J Pharmacol. 2006;531(1-3):176-82. Doi: https://doi.org/10.1016/j.ejphar.2005.12.032
Escobar AL, Xavier FB. Propriedades fitoterápicas do mel de abelhas. Revista Uningá. 2013;37(1). Doi: https://doi.org/10.46311/2318-0579.37.eUJ1115
Citó AM, Barros ED, Moura AK, Cruz ES, Lima JS Neto. Caracterização de compostos voláteis e da fração apolar do mel, própolis e cera de abelha (Apis mellifera) de Picos – Piauí. In: Oliveira-Junior JM, Calvão LB, organizators. A interface do conhecimento sobre abelhas 2. Ponta Grossa, PR: Atena; 2020. p. 139-153. Doi: https://doi.org/10.22533/at.ed.368200110
Sforcin JM. Biological properties and therapeutic applications of propolis. Phytother Res. 2016;30(6):894-905. Doi: https://doi.org/10.1002/ptr.5605
Ni J, Wu Z, Meng J, Zhu A, Zhong X, Wu S, et al. The neuroprotective effects of Brazilian green propolis on neurodegenerative damage in human neuronal SH-SY5Y cells. Oxid Med Cell Longev. 2017;2017. Doi: https://doi.org/10.1155/2017/7984327
Zulhendri F, Perera CO, Tandean S. Can propolis be a useful adjuvant in brain and neurological disorders and injuries? A systematic scoping review of the latest experimental evidence. Biomedicines. 2021;9(9):1227. Doi: https://doi.org/10.3390/biomedicines9091227
Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein (São Paulo). 2010;8:102-6. Doi: https://doi.org/10.1590/S1679-45082010RW1134
Mendes KD, Silveira RC, Galvão CM. Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto & Contexto Enferm. 2019;28:e20170204. Doi: https://doi.org/10.1590/1980-265X-TCE-2017-0204
Santos CM, Pimenta CA, Nobre MR. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev Latino-Am Enfermagem. 2007;15:508-11. Doi: https://doi.org/10.1590/S0104-11692007000300023
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;71:1-9. Doi: https://doi.org/10.1016/j.ijsu.2021.105906
Zhu A, Wu Z, Zhong X, Ni J, Li Y, Meng J, et al. Brazilian green propolis prevents cognitive decline into mild cognitive impairment in elderly people living at high altitude. J Alzheimers Dis. 2018;63(2):551-60. Doi: https://doi.org/10.3233/jad-170630
Wang H, Lu Y, Chen H-Z. Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice. Neurosci Lett. 2003;344(3):173-6. Doi: https://doi.org/10.1016/S0304-3940(03)00444-0
Chen J, Long Y, Han M, Wang T, Chen Q, Wang R. Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice. Pharmacol Biochem Behav. 2008;90(3):441-6. Doi: https://doi.org/10.1016/j.pbb.2008.03.029
Nanaware S, Shelar M, Sinnathambi A, Mahadik KR, Lohidasan S. Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: Impact on behavioral and biochemical parameters in rats. Biomed Pharmacother. 2017;93:543-53. Doi: https://doi.org/10.1016/j.biopha.2017.06.072
Hussein UK, Hassan NE, Elhalwagy ME, Zaki AR, Abubakr HO, Venkata KC, et al. Ginger and propolis exert neuroprotective effects against monosodium glutamate-induced neurotoxicity in rats. Molecules. 2017;22(11):1928. Doi: https://doi.org/10.3390/molecules22111928
Taysi S, Demir E, Cinar K, Tarakcioglu M. The Radioprotective effects of Propolis and Caffeic acid Phenethyl Ester on radiation-induced oxidative/nitrosative stress in brain tissue. Free Radic Biol Med. 2016;100:S111. Doi: https://doi.org/10.1016/j.freeradbiomed.2016.10.286
Shang H, Bhagavathula AS, Aldhaleei WA, Rahmani J, Karam G,Rinaldi G, et al. Effect of propolis supplementation on C-reactive protein levels and other inflammatory factors: A systematic review and meta-analysis of randomized controlled trials. J King Saud Univ Sci. 2020;32(2):1694-701. Doi: https://doi.org/10.1016/j.jksus.2020.01.003
Omar NA, Abu-Almaaty AH, El-Aziz YM, Abdeen AM, Mohamed FE, Hashem MM, et al. Impacts of Egyptian propolis extract on rat cerebellum intoxicated by aluminum silicate: histopathological studies. Environ Sci Pollut Res. 2019;26:22061-8. Doi: https://doi.org/10.1007/s11356-019-05469-4
Moriguchi S, Inagaki R, Saito T, Saido TC, Fukunaga K. Propolis promotes memantine-dependent rescue of cognitive deficits in APP-KI mice. Mol Neurobiol. 2022;59(7):4630-46. Doi: https://doi.org/10.1007/s12035-022-02876-6
Thomzig A, Laube G, Prüss H, Veh RW.. Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain. J Comp Neurol. 2005;484(3):313-30. Doi: https://doi.org/10.1002/cne.20469
Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury III PL, Tran-Johnson TK, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med. 1999;159(2):174-81. Doi: https://doi.org/10.1001/archinte.159.2.174
Juvale II, Has AT. The evolution of the pilocarpine animal model of status epilepticus. Heliyon. 2020;6(7). Doi: https://doi.org/10.1016/j.heliyon.2020.e04557
Rios AT. Síndrome demencial e modelos experimentais para o estudo de doenças neurodegenerativas [undergraduate thesis]. Fortaleza. Curso de Ciências Biológicas, Universidade Federal do Ceará; 2017. 69 p. http://www.repositorio.ufc.br/handle/riufc/48178
Neha, Sodhi RK, Jaggi AS, Singh N. Animal models of dementia and cognitive dysfunction. Life Sci. 2014;109(2):73-86. Doi: https://doi.org/10.1016/j.lfs.2014.05.017
Balmus IM, Ciobica A, Negura A, Negura L, Anton E. Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease. Psychiatr Danub. 2015;27(4):338-45.
Cacabelos R. Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat. 2007;3(3):303-33. Doi: https://doi.org/10.2147/ndt.s12160181
Müller T. Rivastigmine in the treatment of patients with Alzheimer’s disease. Neuropsychiatr Dis Treat. 2007;3(2):211-8. Doi: https://doi.org/10.2147/nedt.S32211
Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, et al. Memantine for the treatment of dementia: a review on its current and future applications. J Alzheimers Dis. 2018;62(3):1223-40. Doi: https://doi.org/10.3233/jad-170672
Croisile B, Trillet M, Fondarai J, Laurent B, Mauguière F, Billardon M. Long-term and high-dose piracetam treatment of Alzheimer's disease. Neurology. 1993;43(2):301. Doi: https://doi.org/10.1212/wnl.43.2.301
Flicker L, Grimley EJ; Cochrane Dementia and Cognitive Improvement Group. Piracetam for dementia or cognitive impairment. Cochrane Database of Syst Rev. 1996;2012(2). Doi: https://doi.org/10.1002/14651858.CD001011
Gonçalves AC, Rodrigues M, Santos AO, Alves G, Silva LR. Antioxidant status, antidiabetic properties and effects on Caco-2 cells of colored and non-colored enriched extracts of sweet cherry fruits. Nutrients. 2018;10(11):1688. Doi: https://doi.org/10.3390/nu10111688
Shimazawa M, Chikamatsu S, Morimoto N, Mishima S, Nagai H, Hara H. Neuroprotection by Brazilian green propolis against in vitro and in vivo ischemic neuronal damage. Evid Based Complement Alternat Med. 2005;2:201-7. Doi: https://doi.org/10.1093/ecam/neh078
El-Sharkawy HM, Anees MM, Van Dyke TE. Propolis improves periodontal status and glycemic control in patients with type 2 diabetes mellitus and chronic periodontitis: a randomized clinical trial. J Periodontol. 2016;87(12):1418-26. Doi: https://doi.org/10.1902/jop.2016.150694
Silveira M, Teles F, Melo E, Borges V, Miranda F, Dutra F, et al. Effects of Brazilian green propolis extract (Epp-Af) on inflammation in hemodialysis patients. Nephrol Dial Transplant. 2020;35(suppl. 3):1894. Doi: https://doi.org/10.1093/ndt/gfaa142.P1574
De Sarno P, Bijur GN, Zmijewska AA, Li X, Jope RS. In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors. Neurobiol Aging. 2006;27(3):413-22. Doi: https://doi.org/10.1016/j.neurobiolaging.2005.03.003
De-Mello N, Souza IQ Junior, Carobrez AP. Pilocarpine prevents age-related spatial learning impairments in rats. Behav Brain Res. 2005;158(2):263-8. Doi: https://doi.org/10.1016/j.bbr.2004.09.006
Messer WS. Cholinergic agonists and the treatment of Alzheimer's disease. Curr Top Med Chem. 2002;2:353-8. Doi: https://doi.org/10.2174/1568026024607553
Foster DJ, Choi DL, Conn PJ, Rook JM. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia. Neuropsychiatr Dis Treat. 2014;10:183-91. Doi: https://doi.org/10.2147/NDT.S55104
Scarpa M, Hesse S, Bradley SJ. M1 muscarinic acetylcholine receptors: a therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease? Adv Pharmacol. 2020;88:277-310. Doi: https://doi.org/10.1016/bs.apha.2019.12.003
Tamfu AN, Tagatsing FM, Talla E, Ozturk M, Mbafor JT, Duru ME. Chemical composition and evaluation of anticholinesterase activity of essential oil from Cameroonian propolis. Issues Biol. Sci. Pharm. Res. 2019;7(3):58-63. Doi: https://doi.org/10.15739/ibspr.19.007
Boulechfar S, Zellagui A, Chemsa AE, Bensouici C, Segueni N, Lahouel M, et al. Investigation of Antioxidant and Anticholinesterase Potential of Essential Oil and Methanolic Extract of Propolis from Mila Region. Journal of Biologically Active Products from Nature. 2019 Nov 2;9(6):434–44. Doi: https://doi.org/10.1080/22311866.2019.1703816
Downloads
Published
Issue
Section
License
Copyright (c) 2024 José Gustavo Queiroz do Nascimento, Izadora, Francisco das Chagas Sousa Rocha, João Antônio Leal De Miranda; Maria Francilene Souza Silva, Jociane Sthefanny Tavares Silva
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
Funding data
-
Fundação de Amparo à Pesquisa do Estado do Piauí
Grant numbers 004/2022
